United Kingdom news from FiercePharma
News
Roche cuts Tarceva price for U.K.
Need more evidence that the U.K. is playing hardball on drug prices? Here it is: The National Institute for Health and Clinical Excellence agreed to pay for Roche's lung cancer med Tarceva--if and... Read more...
ED drug scrips go online in U.K.
U.K. men afraid to discuss a small, er, problem with their doctors will now be able to get their prescription online. That's right, two British pharmacies will begin prescribing ED meds via their... Read more...
NICE urges docs to curtail ADHD meds
Can parents treat ADHD? The U.K.'s National Institute for Health and Clinical Excellence says the first line of treatment for attention deficit hyperactivity disorder should be parental management.... Read more...
Moody's downgrades Euro-Pharma
European pharma companies aren't looking too rosy, either--at least according to Moody's. The ratings agency says the drugmakers--including heavyweights Roche, GlaxoSmithKline, Sanofi-Aventis,... Read more...
Does NICE want pricing power?
Last week, the chief of the U.K.'s National Institute for Health and Clinical Excellence accused drug companies of overpricing their products. Now, sources are telling PharmaTimes that the attack... Read more...
NICE wants to limit anti-TNF use
Hear those cries of protest? They're coming from the U.K., whose National Institute for Health and Clinical Excellence (NICE) issued guidelines today that would limit patients' access to high-tech... Read more...
More NICE debate over cancer meds
It's not just Roche that refused to fork over cost-effectiveness info on its cancer med to the U.K.'s National Institution for Clinical Health and Excellence. So, too, has Merck Serono. Yesterday,... Read more...
Get more United Kingdom coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
